Jundishapur Journal of Natural Pharmaceutical Products
The Official Journal of Ahvaz Jundishapur University of Medical Sciences
Image Credit:Jundishapur J Nat Pharm Prod
Outline
Artificial Intelligence in Drug Discovery: Computational Chemistry, Natural Products, and Clinical Translation
Footnotes
AI Use Disclosure:The author declares that no generative AI tools were used in the creation of this article.
Authors' Contribution:The author was responsible for the conception and design of the work, literature review, drafting and revising the manuscript, and approval of the final version.
Conflict of Interests Statement:The author declares no conflict of interest related to this manuscript.
Ethical Approval:Ethical approval was not required for this work, as it did not involve laboratory experiments, human participants, animal subjects, or the collection of personal data.
Funding/Support:No funding or financial support was received for this work.
References
- 1.Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-477. [PubMed ID: 30976107]. [PubMed Central ID: PMC6552674]. https://doi.org/10.1038/s41573-019-0024-5.
- 2.Bender A, Thomas MC, Scannell JW, Shaywitz DA, Ghiandoni GM, Greener JG, et al. Artificial intelligence in drug discovery-what it is, where we stand and the path forward. Nat Rev Drug Discov. 2026;7:1-22. [PubMed ID: 42567977]. https://doi.org/10.1038/s41573-026-01496-2.
- 3.Schneider G. Automating drug discovery. Nat Rev Drug Discov. 2018;17(2):97-113. [PubMed ID: 29242609]. https://doi.org/10.1038/nrd.2017.232.
- 4.Zhavoronkov A, Ivanenkov YA, Aliper A, Veselov MS, Aladinskiy VA, Aladinskaya AV, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019;37(9):1038-1040. [PubMed ID: 31477924]. https://doi.org/10.1038/s41587-019-0224-x.
- 5.Abkhiz S, Tarighi P, Azizian H. Dual inhibitors of c-MET and EGFR in triple-negative breast cancer: pharmacophore modeling and molecular dynamics-based in silico drug repositioning. Iran J Pharm Res. 2025;24(1). e164183. [PubMed ID: 41234389]. [PubMed Central ID: PMC12606863]. https://doi.org/10.5812/ijpr-164183.
- 6.Nassiri Koopaei M, Moghimirad P, Saeedian Moghadam E, Nassiri Koopaei N, Amanlou M, Akbarzadeh T, et al. Design, synthesis, anticonvulsant evaluation, and molecular docking studies of new GABAA agonist derivatives. Iran J Pharm Res. 2025;24(1). e157392. [PubMed ID: 40718438]. [PubMed Central ID: PMC12296643]. https://doi.org/10.5812/ijpr-157392.
- 7.Sumitomo Dainippon Pharma Co Ltd, Exscientia Ltd. Sumitomo Dainippon Pharma Co Ltd, Exscientia Ltd. Sumitomo Pharma; 2020, [cited 2026 Sep 21]. Sumitomo Dainippon Pharma and Exscientia joint development: new drug candidate created using artificial intelligence (AI) begins clinical study. Available from: https://www.sumitomo-pharma.com/news/20200130.html.
- 8.Xu Z, Ren F, Wang P, Cao J, Tan C, Ma D, et al. A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial. Nat Med. 2025;31(8):2602-2610. [PubMed ID: 40461817]. [PubMed Central ID: PMC12353801]. https://doi.org/10.1038/s41591-025-03743-2.
- 9.Walters WP, Barzilay R. Critical assessment of AI in drug discovery. Expert Opin Drug Discov. 2021;16(9):937-947. [PubMed ID: 33870801]. https://doi.org/10.1080/17460441.2021.1915982.
- 10.Jiménez-Luna J, Grisoni F, Schneider G. Drug discovery with explainable artificial intelligence. Nat Mach Intell. 2020;2(10):573-584. https://doi.org/10.1038/s42256-020-00236-4.
- 11.Liu X, Liu H. Evaluating AI-generated molecules for drug discovery: from generic metrics to translational readiness. Int J Mol Sci. 2026;27(13):5916. [PubMed ID: 42450185]. [PubMed Central ID: PMC13362286]. https://doi.org/10.3390/ijms27135916.
- 12.Najafi M, Shokoohinia Y, Mojarrab M. Acetylenic metabolites and a 2-phenoxychromone derivative from the aerial parts of Artemisia biennis. Iran J Pharm Res. 2025;24(1). e160050. [PubMed ID: 40708931]. [PubMed Central ID: PMC12285677]. https://doi.org/10.5812/ijpr-160050.
- 13.Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov. 2023;22(11):895-916. [PubMed ID: 37697042]. [PubMed Central ID: PMC13118512]. https://doi.org/10.1038/s41573-023-00774-7.
- 14.Malekzadeh R, Arjmand M, Akbari Z, Sadeghi S, Haji Hosseini R. The effect of Xanthium strumarium root extracts on growth inhibition of epithelial ovarian cancer SK-OV-3 cell line: a metabolomics-based study. Jundishapur J Nat Pharm Prod. 2023;18(2). e135038. https://doi.org/10.5812/jjnpp-135038.
- 15.Ahmadi M, Akbari Z, Zamani Z, Haji Hosseini R, Arjmand M. Study the mechanism of antileishmanial action of Xanthium strumarium against amastigotes stages in Leishmania major: a metabolomics approach. Jundishapur J Nat Pharm Prod. 2021;16(3). e106431. https://doi.org/10.5812/jjnpp.106431.
- 16.Wang L, Han Y, Lei Y, Liu J, Yu J, Li G. Quercetin induces macrophage polarization through PI3K-AKT pathway in atherosclerosis: network pharmacology, molecule docking and in vitro analysis. Iran J Pharm Res. 2026;25(1). e168202. [PubMed ID: 42170638]. [PubMed Central ID: PMC13187692]. https://doi.org/10.5812/ijpr-168202.
- 17.Soheili S, Rezghi Barez S, Siadat SD, Hejazi SH, Abtahi H. In silico and in vitro characterization of Lactobacillus acidophilus bacteriocins as ROR-1-targeted therapeutics in breast cancer. Iran J Pharm Res. 2025;24(1). e163509. [PubMed ID: 41477115]. [PubMed Central ID: PMC12749213]. https://doi.org/10.5812/ijpr-163509.
- 18.Shamsi M, Mohammadzadeh G, Hatami M, Roshanazadeh M, Noor-Behbahani M, Rashidi M. Dual modulation of canonical and non-canonical TGF-β/ROS/Erk1/2 pathways: synergistic activation of Nrf-2 and antioxidant enzymes (SOD1, GPx, HO-1) by quercetin loaded in solid lipid nanoparticles and curcumin in atherosclerosis therapy. Iran J Pharm Res. 2024;23(1). e151428. [PubMed ID: 40066126]. [PubMed Central ID: PMC11892753]. https://doi.org/10.5812/ijpr-151428.
- 19.Jafarpour S, Asefzadeh M, Aboutaleb E. The application of machine learning in predicting the permeability of drugs across the blood-brain barrier. Iran J Pharm Res. 2024;23(1). e149367. [PubMed ID: 40066117]. [PubMed Central ID: PMC11892787]. https://doi.org/10.5812/ijpr-149367.
Copyright
Copyright © 2026, Rezaee. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review
Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M. Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review. Iran J Pharm Res. 2024;23(1):e150510. doi: https://doi.org/10.5812/ijpr-150510
Nanodrugs and Natural Pharmaceutical Products
Abbaspour M. Nanodrugs and Natural Pharmaceutical Products. Jundishapur J Nat Pharm Prod. 2012;7(2):39-40. doi: https://doi.org/10.17795/jjnpp-5242
Artificial Intelligence and Migraine: Insights and Applications
Shaterian N, Soltani A, Samieefar N, Akhlaghdoust M. Artificial Intelligence and Migraine: Insights and Applications. Interv Pain Med Neuromod. 2022;2(1):e127675. doi: https://doi.org/10.5812/ipmn-127675
Clinical Application of Artificial Intelligence in Cancer Treatment: A Systematic Literature Review
Shahraki-Mohammadi A, Aliabadi A, Karimi A. Clinical Application of Artificial Intelligence in Cancer Treatment: A Systematic Literature Review. Health Scope. 2025;14(2):e158492. doi: https://doi.org/10.5812/healthscope-158492
The Role of Artificial Intelligence and Machine Learning Techniques: Race for COVID-19 Vaccine
Kannan S, Subbaram K, Ali S, Kannan H. The Role of Artificial Intelligence and Machine Learning Techniques: Race for COVID-19 Vaccine. Arch Clin Infect Dis. 2020;15(2):e103232. doi: https://doi.org/10.5812/archcid.103232
- Scopus by DOI: 0
Last Update: 17 hours ago
- Scopus by Title: 0
Last Update: 17 hours ago
- Scopus by Title (Ref): 0
Last Update: 17 hours ago
- CrossRef: 0
Last Update: 1 day ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 5 days ago